Maria Holmlund elected new member of Biovica board of directors

Maria Holmlund was elected as a new member of the Biovica board of directors at an extra shareholders meeting held on March 30, 2016.

Maria has 30 years of experience in the life science and diagnostic industry and she has previously held senior management positions as CEO, business area manager and marketing manager at international diagnostic companies such as Pharmacia Diagnostics, Boehringer Mannheim, Roche Scandinavia, Phadia and Thermo Fisher. She has extensive experience of successfully introducing novel diagnostic products globally. Maria is currently working with strategic marketing for Chundsell Medical.

“It’s very exciting to join Biovica.The company has a unique diagnostic product that meets
a real unmet need in today’s cancer care. Early evaluation of cancer treatment is very important for both physicians and patients and new diagnostic tools such as DiviTum TM are needed“ says Maria Holmlund

“Maria’s unique expertise in diagnostics and experience to introduce new diagnostic products on the market will be very valuable to Biovica.The company is in an exciting phase with a growing trial program with a number of leading oncologists, and in parallel we are focusing on launching our product DiviTum TM. Maria Holmlund addition to the Board will be very valuable for Biovica.“ Says Anders Rylander, CEO of Biovica.


Anders Rylander, CEO
Direct +46 (0) 18 44 44 835

2017-01-03T10:47:40+00:00 May 4th, 2016 14:00|Regulatory|